Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...

A new study led by Bucknell University Professor Karlo Malaga, biomedical engineering, has identified key insights into optimizing deep brain stimulation (DBS) for Parkinson's disease patients.

A Miami woman with Parkinson's disease is regaining control of her hands and daily life after undergoing deep brain ...

Medicare covers deep brain stimulation (DBS) for eligible people diagnosed with essential tremors or idiopathic Parkinson’s disease to help reduce tremors and improve daily activities. To qualify for ...

Neuromodulation is an adjunct to medication for Parkinson’s symptom management, with growing interest in whether it could one ...

A pilot for nearly three decades, Greg Smith never thought lower back pain would lead to a diagnosis of Parkinson’s Disease. “Hard to walk. Hard to stand up. Very uncomfortable,” Greg says. He went to ...

Global health-tech major Medtronic has launched its Adaptive Deep Brain Stimulation (aDBS) system in India to improve the ...

Nat Clin Pract Neurol. 2008;4(8):424-426. Several factors limit the capacity of the clinical results to date to rule out DBS as a neuroprotective therapy. First, continued functional decline does not ...

Medtronic has won FDA approval for a device that can help with therapy for those suffering from Parkinson’s Disease. The Dublin-based company’s BrainSense Adaptive deep brain stimulation (aDBS) and ...

The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode identifier) for people with Parkinson's disease, Medtronic announced Monday. Like ...